Filana Therapeutics
Business Services · Texas, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
6801 N Capital of Texas Hwy Ste 1, Austi...Phone Number
(512) 501-2444Website
www.filanatx.comRevenue
<$5 MillionStock Symbol
FLNAIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Filana Therapeutics
Filana Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing investigational therapies that target the filamin A (FLNA) protein to treat central nervous system disorders. Headquartered in Austin, Texas,Explore more
Popular SearchesFilana Therapeutics IncSIC Code 87,873NAICS Code 54,541Ticker NASDAQ: FLNAShow moreFilana Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Filana Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Filana Therapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Filana Therapeutics has new funding data
Congratulate Masked Content for being promoted to Masked Content at Filana Therapeutics
Filana Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Filana Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Filana Therapeutics is spiking on competitors!
Product Launch: Get notified when Filana Therapeutics launches new products
Click to see if Filana Therapeutics had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Filana Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Filana Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Filana Therapeutics.
Filana Therapeutics News & Media
Filana Therapeutics Reports Q2 2026 Financial Results and Provides Business Update
AUSTIN, Texas, July 29, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing therapies for Tuberous Sclerosis Complex (TSC)-related epilepsy, today reported financial results for the second quarter ended June 30, 2026 and provided a business update.Filana Therapeutics Reports Q1 2026 Financial Results and Business Update
AUSTIN, Texas, May 07, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company currently focused on developing therapies for Tuberous Sclerosis Complex (TSC)-related epilepsy, today reported financial results for the first quarter ended March 31, 2026 and provided a business update on the development of simufilam, an oral small molecule intended to modulate filamin A protein.Filana Therapeutics Presents TSC-Related Epilepsy Program at Eilat XVIII
Presentation described the biological rationale for the evaluation of simufilam in TSC-related epilepsy Presentation described the biological rationale for the evaluation of simufilam in TSC-related epilepsyFilana Therapeutics Announces Publication in Epilepsia of Preclinical Simufilam Data
AUSTIN, Texas, April 15, 2026 (GLOBE NEWSWIRE) -- Filana Therapeutics, Inc. (NASDAQ: FLNA, “Filana Therapeutics”, the “Company”), a biotechnology company focused on developing therapies for Tuberous Sclerosis Complex (TSC)-related epilepsy, today announced publication in Epilepsia of preclinical data showing that simufilam attenuated seizure progression in a well-accepted mouse model of severe TSC-related epilepsy1. The results support the continued evaluation of simufilam for the treatment of T
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Filana Therapeutics
Sign Up For FreeTo access detailed company insights
Filana Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing investigational therapies that target the filamin A (FLNA) protein to treat central nervous system disorders. Headquartered in Austin, Texas,... Read More
